check_circleStudy Completed

Hypertension, Postmenopause, Hormone Replacement Therapy

Bayer Identifier:

91000

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available
Study to evaluate the effect of a preparation containing DRSP 3 mg and E2 1 mg on blood pressure in mildly hypertensive postmenopausal women

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

N/A

Age

N/A

Trial summary

Enrollment Goal
213
Trial Dates
July 2001 - April 2003
Phase
Phase 3
Could I Receive a placebo
N/A
Products
Angeliq (E2/DRSP, BAY86-4891)
Accepts Healthy Volunteer
N/A

Primary Outcome

Secondary Outcome

Trial design

A multicenter, double-blind, randomized, placebo-controlled study to evaluate the effect of a continuous-combined HRT preparation containing DRSP 3 mg and E2 1 mg on blood pressure in mildly hypertensive postmenopausal women
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.